Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Andrew Mendelsohn is focused on understanding the biology of aging/regeneration and developing therapeutics for diseases associated with aging. He founded the 501(c)(3) non-profit Regenerative Sciences Institute in 1994 to pursue research at the interface of aging, regeneration, and what is now called synthetic biology. In 1997, he co-authored one of the earliest papers in synthetic biology. He has served as Director of Molecular Biology at the Panorama Research Institute, which seeks to develop state-of-the-art antibody-based therapeutics and is a cofounder of several biotechnology companies including Wintgen LLC which seeks to alter Wnt pathway regulation to cure inflammatory and fibrotic diseases. He also serves as Director of Research at Regenerative Sciences Institute (www.regensci.org), which seeks to treat aging by using synthetic and computational biology to engineer enhanced regeneration and rejuvenation. At the heart of our approach is the creation and insertion of new biological programs into cells to augment pre-existing incomplete regeneration mechanisms.